International Journal of Drug Policy
Volume 16 , Pages 31-44 , December 2005

Effectiveness of sterile needle and syringe programmes

Received 11 January 2005 ,Revised 4 February 2005 ,Accepted 6 February 2005.

References 

  1. Abdala N, Stephens PC, Griffith BP, Heimer R. Survival of HIV-1 in syringes. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999;20(1):73–80
  2. Aceijas, C. (2004). Personal communication.
  3. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programes: Current issues and future prospects. Social Science & Medicine. 2000;51(12):1771–1782
  4. Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited drug users in Oakland, California, 1992 to 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(5):505–511
  5. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: A cohort study. AIDS. 2000;14(5):605–611
  6. Bluthenthal RN, Gogineni A, Longshore D, Stein M. Factors associated with readiness to change drug use among needle-exchange users. Drug and Alcohol Dependence. 2001;62:225–230
  7. Broadhead RS, van Hulst Y, Heckathorn DD. The impact of a needle exchange's closure. Public Health Reports. 1999;114:439–447
  8. Bruneau J, Lamothe F, Franco E, Lachance N, Désy M, Soto J, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology. 1997;146:994–1002
  9. Burns SM, Brettle RP, Gore SM, Peutherer JP, Robertson JR. The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: An historical perspective and new insight regarding the past incidence of HIV infection and derived from retrospective HIV antibody testing of stored samples of serum. The Journal of Infection. 1996;32:53–62
  10. Chitwood DD, McCoy CB, Inciardi JA, McBride DC, Comerford M, Trapido E, et al. HIV seropositivity of needles from shooting galleries in South Florida. American Journal of Public Health. 1990;80:150–152
  11. Chitwood DD, Griffin DK, Comerford M, Page JB, Trapido EJ, Lai S, et al. Risk factors for HIV-1 seroconversion among injection drug users: A case–control study. American Journal of Public Health. 1995;85:111538–111542
  12. Coutinho, R. A. M. D. P. (2000, September). Needle exchange, pragmatism, and moralism. American Journal of Public Health Women's Health/Needle Exchange, 90(9), 1387–1388.
  13. Cox GM, Lawless MC, Cassin SP, Geoghegan TW. Syringe exchanges: A public health response to problem drug use. Irish Medical Journal. 2000;93(5):143–146
  14. Crofts N, Aitken CK, Kaldor MJ. The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal of Australia. 1999;170:220–221
  15. Des Jarlais DC, Friedman SR, Sotheran JL, Wenston J, Marmor M, Yancovitz SR, et al. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. The Journal of the American Medical Association. 1994;271(2):121–127
  16. Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. The Journal of the American Medical Association. 1995;274(15):1226–1231
  17. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348(9033):987–991
  18. Des Jarlais DC, Perlis T, Friedman S, Chapman T, Kwok J, Rockwell R, et al. Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990–1997. American Journal of Public Health. 2000;90(7):1112–1116
  19. Doherty MC, Junge B, Rathouz P, Garfein RS, Riley E, Vlahov D. The effect of needle exchange program on numbers of discarded needles: A 2-year follow-up. American Journal of Public Health. 2000;90(6):936–939
  20. Dolan K, Wodak A, Hall W, Kaplan E. A mathematical model of HIV transmission in NSW prisons. Drug and Alcohol Dependence. 1998;50:197–202
  21. Dolan K, Rutter S, Wodak AD. Prison based syringe exchange programs: A review of international research and development. Addiction. 2003;98:153–158
  22. Donoghoe MC, Dolan K, Stimson GV. Life-style factors and social circumstances of syringe sharing in injecting drug users. British Journal of Addiction. 1992;87:993–1003
  23. Donoghoe MC, Stimson GV, Dolan KA, Alldrit L. Changes in HIV risk behaviour in clients of syringe-exchanges schemes in England and Scotland. AIDS. 1989;3:267–272
  24. Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997;92(11):1457–1465
  25. Frischer M, Elliot L, Taylor A, et al. Do needle exchanges help to control the spread of HIV among injecting drug users. AIDS. 1993;7:1677–1678
  26. General Accounting Office, G. A. (1993). Needle exchange programs: Research suggests promise as an AIDS prevention strategy. Washington, DC: US Government Printing Office.
  27. Gibson, D. R. (2000). Two- to sevenfold decreased risk associated with use of needle exchange, Paper presented at the University of California, 3rd annual conference on AIDS research in California, 17th annual AIDS investigators’ meeting, University of California, South San Francisco, California, February 25, 2000.
  28. Gibson DR, Flynn NM. Some observations concerning the contrary evidence of syringe exchange effectiveness. San Francisco: AIDS Research Institute, University of California; 2001;http://ari.ucsf.edu/pdf/Posters/gibson_caps.pdf (accessed 8th July 2005)
  29. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001, July;15(11):1329–1341
  30. Gleghorn AA, Jones TS, Doherty MC, Celentano DD, Vlahov D. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1995;10(1):97–103
  31. Gleghorn AA, Wright-De Aguero L, Flynn C. Feasibility of one-time use of sterile syringes: A study of active injection drug users in seven United States Metropolitan areas. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(Suppl. 1):S30–S36
  32. Gold M, Gafni A, Nelligan P, Millson P. Needle exchange programs: An economic evaluation of a local experience. Canadian Medical Association Journal. 1997;157(3):255–262
  33. Gray J. Operating needle exchange programmes in the hills of Thailand. AIDS Care. 1995;7(4):489–499
  34. Guydish J, Bucardo J, Young M, Woods W, Grinstead O. Evaluating needle exchange: Are there negative effects?. AIDS. 1993;7:871–876
  35. Guydish J, Clark G, Garcia D, Bucardo J. Evaluation of needle exchange using street-based survey methods. Journal of Drug Issues. 1995;25:33–41
  36. Guydish J, Bucardo J, Clark G, Bernheim S. Evaluating needle exchange: A description of client characteristics, health status, program utilization, and HIV risk behavior. Substance Use and Misuse. 1998;33:1173–1196
  37. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health. 1995;85(11):531–537
  38. Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment. 2000;19(3):247–252
  39. Hartgers C, Buning EC, van Santen GW, Verster AD, Coutinho RA. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS. 1989;3(9):571–576
  40. Hartgers C, Van Ameijden EJ, van den Hoek JA, Coutinho RA. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting users. Public Health Reports. 1992;107(6):675–681
  41. Health Outcomes International (HOI), N.D., M. (2002). Return on investment in needle and syringe programs in Australia. Canberra: Commonwealth Department of Health and Ageing.
  42. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe use and reuse: Effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(Suppl. 1):S37–S44
  43. Heimer R, Kaplan EH, Khoshnood K, Jariwala B, Cadman EC. Needle exchange decreases the prevalence of HIV-1 Proviral DNA in returned syringes in New Haven, Connecticut. The American Journal of Medicine. 1993;95(2):214–220
  44. Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(Suppl. 1):S133–S138
  45. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997;349:1797–1800
  46. Inciardi JA, Page JB, McBride DC, Chitwood DD, McCoy CB, McCoy HV, et al. In:  Inciardi JA,  McElrath K editor. The risk of exposure to HIV-contaminated needles in shooting galleries in The American Drug Scene. Los Angeles, LA: Roxbury Press; 1994;
  47. Institute of Medicine of the National Academy of Science. (2001). No time to lose: Getting more from HIV prevention. Washington, DC: National Academies Press.
  48. Jacobs P, Calder P, Taylor M, Houston S, Saunders LD, Albert T. Cost effectiveness of Streetworks’ needle exchange program of Edmonton. Canadian Medical Association Journal. 1999;90(3):168–171
  49. Jenkins C, Rahman H, Saidel T, Jana S, Hussain AMZ. Measuring the impact of needle exchange programs among injecting drug users through the National Behavioural Surveillance in Bangladesh. AIDS Education and Prevention. 2001;13(5):452–461
  50. Junge B, Valente T, Latkin C, Riley E, Vlahov D. Syringe exchange not associated with social network formation: Results from Baltimore. AIDS. 2000;14(4):423–426
  51. Kahn J. Economic evaluation of primary HIV prevention in injection drug users. In:  Holtgrave DR editors. Handbook of economic evaluation HIV prevention programs. New York: Plenum Press; 1998;
  52. Kahn J, Sanstad KC. The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS and Public Policy Journal. 1997;12(1):21–30
  53. Kahn JG, Washington AE, Showstack JA, et al. Updated estimates of the impact and cost of HIV prevention in injection drug users. San Francisco: Centers for Disease Control, Institute for Health Policy Studies, University of California; 1992;
  54. Kaplan EH. Evaluating needle exchange programs via syringe tracking and testing. AIDS and Public Policy. 1991;6:109–115
  55. Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven's needle exchange program: Client shift or needle exchange?. American Journal of Public Health. 1994;84:1991–1994
  56. Kaplan EH, Heimer R. HIV incidence among New Haven needle exchange participants: Updated estimates from syringe tracking and testing data. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 1995;10(2):175–176
  57. Klee H, Faugier J, Hayes C, Morris J. The sharing of injection equipment among drug users attending prescribing clinics and those using needle exchange. British Journal of Addiction. 1991;86:217–223
  58. Klee H, Morris J. The role of needle exchanges in modifying sharing behaviour: Cross-study comparisons 1989–1993. Addiction. 1995;90:1635–1645
  59. Keene J, Stimson GV, Jones S, Parry-Langdon N. Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales. Addiction. 1993;88(8):1063–1070
  60. Kumaranayake, L., Vickerman, P., Walker, D., Samoshkin, S., Romantzov, V., Emelyanova, Z., et al. (2000). The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus (draft). Geneva: UNAIDS.
  61. Latkin CA, Forman VL. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, USA. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2001;27(4):398–404
  62. Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndromes. 2001;28(3):273–278
  63. Lima ES, Friedman SR, Bastos FI, Telles PR, Friedmann P, Ward TP, et al. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment in Rio de Janeiro. Addiction. 1994;89(6):689–698
  64. Lines, R., Jürgens, R., Stöver, H., Laticevschi, D., & Nelles, J. (2004). Prison needle exchange: A review of international evidence and experience (Canadian HIV/AIDS Legal Network, Montreal). Available at www.aidslaw.ca (accessed 8 December 2004).
  65. Ljungberg B, Christensson B, Tunving K, Andersson B, Landvall B, Lundberg M, et al. HIV prevention among injecting drug users: Three years of experience from a syringe exchange program in Sweden. Journal of Acquired Immune Deficiency Syndromes. 1991;4(9):890–895
  66. Lowndes CM, Alary M. Re: “High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study”. American Journal of Epidemiology. 1998;148(7):713–714author reply 716–717
  67. Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. The Lancet. 1997;349(9052):604–608
  68. Lurie P, Gorsky R, Jones ST, Shomphe L. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(Suppl. 1):S126–S132
  69. McCoy CB, Shapshak P, Shah SM, McCoy HV, Rivers JE, Page JB, et al. HIV-1 prevention: Interdisciplinary studies and reviews on efficacy of bleach and compliance to bleach prevention protocols. In: Proceedings of the Workshop on Needle Exchange and Bleach Distribution Programs. Washington, DC: National Academy Press; 1995;
  70. Monterroso ER, Hamburger ME, Vlahov D, Des Jarlais DC, Ouellet LJ, Altice FL, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2000;25(1):63–70
  71. National Commission on Acquired Immune Deficiency Syndrome. (1991). The twin epidemics of substance use and HIV. Washington, DC: Government Printing Office.
  72. National Institutes of Health Consensus Panel. (1997). Interventions to prevent HIV risk behaviors. NIH.
  73. Nelles J, Harding T. Preventing HIV transmission in prison: A tale of medical disobedience and Swiss pragmatism. Lancet. 1995;346(8989):1507–1508
  74. Nelson KE, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony JC. Human immunodeficiency virus infection in diabetic intravenous drug users. The Journal of the American Medical Association. 1991;266(16):2259–2261
  75. Nelson KE, Celentano DD, Eiumtrakol S, Hoover DR, Beyrer C, Suprasert S, et al. Changes in sexual behaviour and a decline in HIV infection among young men in Thailand. The New England Journal of Medicine. 1996;335(5):297–303
  76. In:  Normand J,  Vlahov D,  Moses LE editor. Preventing HIV transmission: The role of sterile needles and bleach. Washington DC: National Academy Press; 1995;
  77. Office of Technology Assessment of the US Congress, (1995). The Effectiveness of AIDS Prevention Efforts, US Government Printing Office. Washington DC.
  78. Oliver KJ, Maynard H, Friedman SR, et al. Behavioral and community impact of the Portland syringe exchange program. In:  Normand J,  Vlahov D,  Moses LE editor. Proceedings of the Workshop on Needle Exchange and Bleach Distribution Programs. Washington, DC: National Academy Press; 1994;p. 35–46
  79. Oliver KJ, Friedman SR, Maynard H, Magnuson L, Des Jarlais DC. Impact of a needle exchange program on potentially infectious syringes in public places. Journal of Acquired Immune Deficiency Syndromes. 1992;5:534–535
  80. Page JB, Chitwood DD, Smith PC, Kane N, McBride DC. Intravenous drug use and HIV infection in Miami. Medical Anthropology. 1990;4:56–71
  81. Paone D, Clark J, Shi Q, Purchase D, Des Jarlais DC. Syringe exchange in the United States, 1996: A national profile. American Journal of Public Health. 1999;89(1):43–46
  82. Paone D, Cooper H, Alperen J, Shi Q, Des Jarlais DC. HIV risk behaviours of current sex workers attending syringe exchange: The experiences of women in five US cities. AIDS Care. 1999;11:269–280
  83. Paone D, Des Jarlais DC, Caloir S, Friedman PB, Ness I, Friedman SR. New York City syringe exchange: An overview. In: Proceedings of the Workshop on Needle Exchange and Bleach Distribution Programs. Washington: National Academy Press; 1994;
  84. Paone D, Des Jarlais DC, Shi Q. Syringe exchange use and HIV risk reduction over time. AIDS. 1998;12(1):121–123
  85. Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD and AIDS. 1997;8:437–445
  86. Peak A, Rana S, Maharjan SH, Jolley D, Crofts N. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: The impact of a harm-reduction programme. AIDS. 1995;9(9):1067–1070
  87. Power RN, Natalya . The value of process evaluation in sustaining HIV harm reduction in the Russian Federation. AIDS. 2002;16(2):303–304
  88. Quan VM, Chung A, Abdul-Quader AS. The feasibility of a syringe-needle-exchange program in Vietnam. Substance Use and Misuse. 1998;33(5):1055–1067
  89. Safaeian M, Brookmayer R, Vlahov D, Latkin C, Harx M, Strathdee SA. Validity of self-reported needle exchange attendance among injection drug users: Implications for program evaluation. American Journal of Epidemiology. 2002;155(2):169–175
  90. Samuels JS, Vlahov D, Anthony JC, Solomon L, Celentano DD. The practice of “frontloading” among intravenous drug users: Association with antibody. AIDS. 1991;5:343–345
  91. Satcher D. Evidence-based findings on the efficacy of syringe exchange programs: An analysis of the scientific research completed since April 1998. Washington, DC: US Department of Health and Human Sciences; 2000;
  92. Schechter M, Strathdee S, Cornelisse PGA, et al. Do needle exchange programs increase the spread of HIV among injection drug users: An investigation of the Vancouver outbreak. AIDS. 1999;13(6):F45–F51
  93. Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users. AIDS. 1996;10:1729–1734
  94. Sears C, Guydish JR, Weltzien EK, Lum PJ. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, USA. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2001;27(2):193–201
  95. Shah SM, Shapshak P, Rivers JE, Stewart RV, Weatherby NL, Xin KQ, et al. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: A preliminary laboratory report. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1996;11(3):301–306
  96. Shapshak P, Fujimura RK, Page JB, Segal D, Rivers JE, Yang J, et al. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: A preliminary laboratory report. Drug and Alcohol Dependence. 2000;58(1/2):153–157
  97. Singer M, Himmelgreen D, Weeks MR, Radda KE, Martinez R. Changing the environment of AIDS risk: Findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Medical Anthropology. 1997;18(1):107–130
  98. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–F65
  99. Strathdee SA, Celentano DD, Shah N, Lyles C, Stambolis VA, Macal G, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health. 1999;76(4):448–460
  100. Strathdee SA, Vlahov D. The effectiveness of needle exchange programs: A review of the science and policy. AIDScience. 2001;1(16):1–33
  101. Telles PR, Bastos FI, Guydish J, Inciardi JA, Surratt HL, Pearl M, et al. Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil. AIDS. 1997;11(Suppl. 1):S35–S42
  102. Van Ameijden EJ, van den Hoek AR, Coutinho RA. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992 and its relationship to AIDS prevention programs. American Journal of Public Health. 1994;84:275–281
  103. Van Ameijden EJ, Coutinho RA. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS. 1998;12(6):625–633
  104. Van Ameijden EJ, Coutinho RA. Large decline in injecting drug use in Amsterdam, 1986–1998: Explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health. 2001;55(5):356–363
  105. Van Ameijden EJ, Langendam MW, Notenboom J, Coutinho RA. Continuing injecting risk behaviour: Results from the Amsterdam Cohort Study of drug users. Addiction. 1999;94(7):1051–1061
  106. Van Ameijden EJ, van den Hoek JAR, van Haastrecht HJA, Coutinho RA. The harm reduction approach and risk factors for human immunodeficiency virus seroconversion in injecting drug users, Amsterdam. American Journal of Epidemiology. 1992;136:236–243
  107. Van Haastrecht HJA, van Ameijden EJC, van den Hoek AA, et al. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-jpositive and HIV-negative drug users. American Journal of Epidemiology. 1996;143:380–391
  108. Vickerman P, Watts C. The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus: Model predictions. International Journal of Drug Policy. 2002;13:149–164
  109. Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndromes. 1997;16:400–406
  110. Vogt RL, Breda MC, Des Jarlais DC, Gates S, Whiticar P. Hawaii's statewide syringe exchange program. American Journal of Public Health. 1998;88(9):1403–1404
  111. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. The Journal of the American Medical Association. 1994;271(2):115–120
  112. Weaver H, Smith G, Kippax S. School-based sex education policies and indicators of sexual health among young people: A comparison of the Netherlands, France, Australia and the United States. Computer Science Education. 2005;5(2):171–188
  113. Weber DJ, Barbee SL, Sobsey MD, Rutala WA. The effect of blood on the antiviral activity of sodium hypochlorite, a phenolic, and a quaternary ammonium compound. Infection Control and Hospital Epidemiology. 1999;20(12):821–827
  114. WHO. (2003). Global health sector strategy for HIV/AIDS 2003–2007. Geneva: WHO.
  115. Wodak A, Dolan K, Imrie AA, Gold J, Wolk J, Whyte BM, et al. Antibodies to the HIV virus in needles and syringes used by intravenous drug abusers. Medical Journal of Australia. 1987;147:275–276
  116. Wolk J, Wodak A, Guinan JJ, Macaskill P, Simpson JM. The effect of a needle and syringe exchange on a methadone maintenance unit. British Journal of Addiction. 1990;85(11):1445–1450

PII: S0955-3959(05)00078-2

doi: 10.1016/j.drugpo.2005.02.004

International Journal of Drug Policy
Volume 16 , Pages 31-44 , December 2005

Article Tools